Bioanalysis of large molecules

Swiss BioQuant develops and validates highly sensitive and specific immunoassays for quantification of peptide or protein therapeutics (biopharmaceuticals) in various types of biological matrices. Drug immunogenicity assessments, determination of anti-drug antibodies (ADA), investigation of neutralization activities of ADA, and  toxicokinetic and pharmacokinetic analysis of biological samples from preclinical PK and  toxicology studies, as well as from clinical studies can be performed.